UROGEN PHARMA LTD's ticker is URGN and the CUSIP is M96088105. A total of 78 filers reported holding UROGEN PHARMA LTD in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $2,497,000 | +1.9% | 148,439 | -7.5% | 0.01% | 0.0% |
| Q2 2021 | $2,451,000 | -24.4% | 160,521 | -3.5% | 0.01% | -28.6% |
| Q1 2021 | $3,240,000 | -48.3% | 166,352 | -52.2% | 0.01% | -46.2% |
| Q4 2020 | $6,268,000 | -14.2% | 347,867 | -8.2% | 0.01% | -18.8% |
| Q3 2020 | $7,309,000 | -3.1% | 378,871 | +31.1% | 0.02% | -11.1% |
| Q2 2020 | $7,546,000 | +125.7% | 288,889 | +54.1% | 0.02% | +100.0% |
| Q1 2020 | $3,343,000 | -16.5% | 187,419 | +56.1% | 0.01% | +12.5% |
| Q4 2019 | $4,005,000 | +1568.8% | 120,042 | +1694.6% | 0.01% | +700.0% |
| Q2 2019 | $240,000 | – | 6,689 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Stonepine Capital Management, LLC | 1,111,050 | $9,099,000 | 4.23% |
| GREAT POINT PARTNERS LLC | 873,424 | $7,153,000 | 1.72% |
| Wildcat Capital Management, LLC | 533,139 | $4,366,000 | 1.45% |
| Opaleye Management Inc. | 238,670 | $1,955,000 | 0.88% |
| MENORA MIVTACHIM HOLDINGS LTD. | 2,949,489 | $24,156,000 | 0.44% |
| Annandale Capital, LLC | 84,331 | $691,000 | 0.27% |
| Yahav Achim Ve Achayot - Provident Funds Management Co Ltd. | 25,330 | $206,000 | 0.18% |
| RTW INVESTMENTS, LP | 857,464 | $7,023,000 | 0.18% |
| Harel Insurance Investments & Financial Services Ltd. | 1,025,611 | $8,400,000 | 0.18% |
| BENDER ROBERT & ASSOCIATES | 41,131 | $337,000 | 0.13% |